Mainz Biomed Shares Are Trading Higher After the Company Announced the Submission for FDA Breakthrough Device Designation for Its CRC Screening Test
Mainz Biomed股票上漲,該公司宣佈爲其CRC篩查測試提交FDA突破性設備認定申請。
Mainz Biomed Shares Are Trading Higher After the Company Announced the Submission for FDA Breakthrough Device Designation for Its CRC Screening Test
Mainz Biomed Shares Are Trading Higher After the Company Announced the Submission for FDA Breakthrough Device Designation for Its CRC Screening Test
Mainz Biomed股票上漲,該公司宣佈爲其CRC篩查測試提交FDA突破性設備認定申請。
使用瀏覽器的分享功能,分享給你的好友吧